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BACKGROUND: Demand for lip filler injection continues to increase. Despite the current literature’s acknowledgement of the role both venous and arterial vasculature
play in minor and major side effects, research addressing
the venous vasculature of the lower one-third of the face
is scarce. The purpose of our study was to create a venous
map demonstrating areas of venous pooling that one should
avoid when injecting, thus improving the safety and overall
aesthetic appearance of the lips postaugmentation.
METHODS: A photographic analysis of the venous vasculature of 26 participants was performed using a vein transilluminator to display the venous flow around the perioral
region. The data were analyzed for commonalities among
participants and then compared with common lip filler
injection techniques and locations.
RESULTS: Venous tributaries were identified in all
patients, with a slight variation in pattern, superior to the
upper vermillion border between the nasolabial fold and
philtral column on each side of the mouth. Venous tributaries were noted about 1.0–1.5 cm lateral to the oral commissures extending inferiorly to the chin and along the
labiomental crease. Four areas of venous pooling were
deemed significant: a small area ~2 mm superior to cupid’s
bow, an area along the middle tubercle of the upper lip, an
area along the wet-dry line of the lower lip, and an area
centrally along the vermillion border between the lower lip
tubercles.
CONCLUSIONS: Perioral venous mapping provides a
guide for injectors performing facial and lip enhancement
procedures in identifying areas at risk for injury due to
venous pooling. Avoiding these anatomically vulnerable
regions can minimize the potential for inflammation and
tissue necrosis associated with intravenous injection and
prevent dissatisfactory aesthetic results such as lumps,
excessive bruising, swelling, or asymmetry.
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BACKGROUND: The use of hyaluronic acid soft tissue
fillers has become exceedingly popular.1,2 Hyaluronic acid
filler injection is generally regarded as a safe procedure.3
However major complications do exist, notably blindness
and skin ischemia/necrosis.4,5 Hyaluronidase is an enzymatic reversal agent for immediate ischemic complications
of hyaluronic acid fillers. Unfortunately, many injector sites
are not equipped with hyaluronidase due to the expensive
price, short shelf-life, and rare incidence of ischemic complications. As a result, emergency rooms (ERs) are expected
to operate as a safety net when injector sites encounter an
ischemic complication. Currently, little is known on the
availability of hyaluronidase in ERs. The authors sought to:
(1) determine the immediate availability of hyaluronidase in
ERs across the state of California; (2) determine the institutional and geographical predictors of hyaluronidase availability; and (3) provide injectors with recommendations to
obtain hyaluronidase when on-site supplies are inadequate.
METHODS: Authors conducted a scripted telephone survey of all Californian ERs, inquiring about hyaluronidase
availability. Proportions of hyaluronidase availability were
compared among different geographical regions, various
trauma center level designations, and children’s hospital
status, using χ2 tests. A Mann-Whitney U test was used
to compare median bed counts between hospitals that had
hyaluronidase available and those that did not.
RESULTS: The present study included 330 Californian
ERs and achieved an 89.7% response rate (n = 296). Overall, 45.6% of ERs were found to not have hyaluronidase in
their pharmacy inventory. Hyaluronidase availability was
positively associated with level I–III adult trauma center status, pediatric trauma center status, children’s hospital status, hospitals with higher median bed counts, and
regional geography (P < 0.05, all). Of note, while dermal
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